Status:

SUSPENDED

7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy

Lead Sponsor:

University of Southern California

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Hypogonadism

Malignant Testicular Germ Cell Tumor

Eligibility:

MALE

18+ years

Brief Summary

This study evaluates 7 Tesla (T) magnetic resonance imaging (MRI) in observing changes in the brain (neuroimaging) in testicular cancer patients who have decreased testosterone (hypogonadism) and are ...

Detailed Description

PRIMARY OBJECTIVE: I. To assess longitudinal structural changes in brain architecture using MRI in hypogonadal men with testis cancer being treated with androgen replacement therapy. OUTLINE: This i...

Eligibility Criteria

Inclusion

  • Males age \>= 18 years
  • Diagnosed with germ cell tumor of the testis (seminoma or non-seminoma) and treated with radical orchiectomy
  • Diagnosed with hypogonadism and started androgen replacement therapy 6 months prior (+/- 2 weeks)
  • Ability to understand and the willingness to sign a written informed consent
  • Ability to undergo imaging procedure without any form of sedation

Exclusion

  • History of any neuropsychiatric disease
  • History of narcotic use or psychiatric medications
  • History of ART prior to current ART regimen
  • Standard contraindications for MRI:
  • Prior work as a machinist or metal worker, or history of metal being removed from the eyes
  • Cardiac pacemaker or internal pacing wires
  • Non-MRI compatible vena cava filter, vascular aneurysm clip, heart valve, spinal or ventricular shunt, optic implant, neuro-stimulator unit, ocular implant, or intrauterine device, or
  • Claustrophobia, or uncontrollable motion disorder
  • Current active second malignancy

Key Trial Info

Start Date :

November 29 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT06191575

Start Date

November 29 2022

End Date

December 31 2027

Last Update

December 22 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Los Angeles County-USC Medical Center

Los Angeles, California, United States, 90033

2

USC / Norris Comprehensive Cancer Center

Los Angeles, California, United States, 90033